RATIONALE: Exposure to drugs during adolescence can induce alterations in the central nervous system. The novelty-seeking personality trait influences differences observed among individuals exposed to drugs of abuse. OBJECTIVES: Long-term effects of intensive pre-treatment with cocaine during adolescence or adulthood were evaluated in High- and Low-Novelty Seeker (HNS and LNS) mice. It was hypothesized that a cocaine binge during adolescence would increase sensitivity to the rewarding effects of cocaine and MDMA, especially in HNS animals, and modify the spontaneous behaviour of adult animals. METHODS: Adolescent (PND 33) and adult (PND 60) mice were identified as HNS or LNS according to their performance in the hole-board test. Subsequently, they received pre-treatment with cocaine (three injections per day of an increasing dose for 10 days) or saline. Three weeks later, the mice performed the hole-board, elevated plus maze, spontaneous locomotor activity and cocaine- (1 mg/kg) or MDMA- (1.25 mg/kg) induced conditioning place preference (CPP) tests. In another set of mice, the effects of pre-treatment of cocaine during adulthood on MDMA- or cocaine-induced CPP were also evaluated 3 weeks later. RESULTS: Only HNS mice treated with cocaine during adolescence acquired MDMA- or cocaine-induced CPP in adulthood. Moreover, pre-exposure to cocaine during adolescence caused subsequent behavioural alterations, including reduced exploratory behaviour and increased locomotor reactivity. CONCLUSIONS: Cocaine binge administration during adolescence induces a higher sensitivity to the rewarding effects of MDMA and cocaine in HNS mice in adulthood. This may explain the greater vulnerability often seen among individuals exposed early in life to drugs of abuse.
RATIONALE: Exposure to drugs during adolescence can induce alterations in the central nervous system. The novelty-seeking personality trait influences differences observed among individuals exposed to drugs of abuse. OBJECTIVES: Long-term effects of intensive pre-treatment with cocaine during adolescence or adulthood were evaluated in High- and Low-Novelty Seeker (HNS and LNS) mice. It was hypothesized that a cocaine binge during adolescence would increase sensitivity to the rewarding effects of cocaine and MDMA, especially in HNS animals, and modify the spontaneous behaviour of adult animals. METHODS: Adolescent (PND 33) and adult (PND 60) mice were identified as HNS or LNS according to their performance in the hole-board test. Subsequently, they received pre-treatment with cocaine (three injections per day of an increasing dose for 10 days) or saline. Three weeks later, the mice performed the hole-board, elevated plus maze, spontaneous locomotor activity and cocaine- (1 mg/kg) or MDMA- (1.25 mg/kg) induced conditioning place preference (CPP) tests. In another set of mice, the effects of pre-treatment of cocaine during adulthood on MDMA- or cocaine-induced CPP were also evaluated 3 weeks later. RESULTS: Only HNS mice treated with cocaine during adolescence acquired MDMA- or cocaine-induced CPP in adulthood. Moreover, pre-exposure to cocaine during adolescence caused subsequent behavioural alterations, including reduced exploratory behaviour and increased locomotor reactivity. CONCLUSIONS:Cocaine binge administration during adolescence induces a higher sensitivity to the rewarding effects of MDMA and cocaine in HNS mice in adulthood. This may explain the greater vulnerability often seen among individuals exposed early in life to drugs of abuse.
Authors: Stephanie E Sillivan; Yolanda D Black; Alipi V Naydenov; Fair R Vassoler; Ryan P Hanlin; Christine Konradi Journal: Biol Psychiatry Date: 2011-05-14 Impact factor: 13.382
Authors: Bruno Ribeiro Do Couto; Manuel Daza-Losada; Marta Rodríguez-Arias; Roser Nadal; Consuelo Guerri; Teresa Summavielle; Jose Miñarro; Maria A Aguilar Journal: Addict Biol Date: 2011-10-13 Impact factor: 4.280
Authors: Nicole L Schramm-Sapyta; Q David Walker; Joseph M Caster; Edward D Levin; Cynthia M Kuhn Journal: Psychopharmacology (Berl) Date: 2009-06-23 Impact factor: 4.530
Authors: M C Arenas; C I Navarro-Francés; S Montagud-Romero; J Miñarro; C Manzanedo Journal: Psychopharmacology (Berl) Date: 2018-06-29 Impact factor: 4.530
Authors: A Mateos-García; C Manzanedo; M Rodríguez-Arias; M A Aguilar; E Reig-Sanchis; C I Navarro-Francés; O Valverde; J Miñarro; M C Arenas Journal: Psychopharmacology (Berl) Date: 2015-05-06 Impact factor: 4.530
Authors: M C Arenas; A Mateos-García; C Manzanedo; M Rodríguez-Arias; M A Aguilar; F Navarrete; M S García Gutiérrez; J Manzanares; J Miñarro Journal: Psychopharmacology (Berl) Date: 2016-09-05 Impact factor: 4.530
Authors: M Carmen Arenas; María A Aguilar; Sandra Montagud-Romero; Ana Mateos-García; Concepción I Navarro-Francés; José Miñarro; Marta Rodríguez-Arias Journal: Curr Neuropharmacol Date: 2016 Impact factor: 7.363
Authors: María A Aguilar; Juan Carlos Ledesma; Marta Rodríguez-Arias; Carles Penalva; Carmen Manzanedo; José Miñarro; M Carmen Arenas Journal: Int J Mol Sci Date: 2017-06-21 Impact factor: 5.923
Authors: Juan Carlos Ledesma; Maria A Aguilar; Pablo Giménez-Gómez; José Miñarro; Marta Rodríguez-Arias Journal: PLoS One Date: 2017-03-14 Impact factor: 3.240
Authors: M Rodríguez-Arias; C Roger-Sánchez; I Vilanova; N Revert; C Manzanedo; J Miñarro; M A Aguilar Journal: Neural Plast Date: 2015-12-31 Impact factor: 3.599